Yu, T.-C. and Chou, W.-C. 2026. Challenges of Hepatitis B Virus Reactivation and CD19 Testing Following Tafasitamab Plus Lenalidomide for Relapsed Diffuse Large B-Cell Lymphoma. Journal of Medical Cases. 17, 5 (Jan. 2026), 231–237. DOI:https://doi.org/10.14740/jmc5313.